Pilot PT Program for Alternative Matrices: Cannabinoids - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Pilot PT Program for Alternative Matrices: Cannabinoids

Description:

Note: See DTAB meeting transcript for verbal comments. Evaluation of Analytical Values Reported for ... Complete in-depth evaluation of immunoassay tests ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 21
Provided by: mitc178
Category:

less

Transcript and Presenter's Notes

Title: Pilot PT Program for Alternative Matrices: Cannabinoids


1
Pilot PT Program for Alternative Matrices
Cannabinoids
  • John M. Mitchell, Ph.D.
  • DTAB meeting
  • June 4, 2002
  • Note See DTAB meeting transcript for verbal
    comments

2
Evaluation of Analytical Values Reported for
Cannabinoids
  • Only confirmatory test values
  • for Urine, GC/MS
  • quantitations are in ng/mL (ppb)
  • for Hair, mostly GC/MS/MS (only 1 or 2 by GC/MS)
  • quantitations are in pg/mg (ppt)
  • for Oral Fluid, some GC/MS and some GC/MS/MS
  • quantitations are in ng/mL (ppb)

3
  • Variance
  • Industry agreed-upon cutoffs
  • Means of values reported by the participating
    laboratories
  • Calculated for samples with three or more values
  • Annotated above each histogram bar
  • Percent coefficient of variation
  • Mathematical indicator of the variation

4
  • Performance around cutoffs
  • Graphs of reported values from each lab versus
    the mean value
  • Containing 20 and 50 quantitation ranges
  • Relative position of cutoff
  • Distribution below the cutoff

5
Source of Analytical Values
  • 2 Urine Maintenance PT Cycles for all labs
    currently certified in the NLCP
  • 4 Hair Pilot PT Cycles
  • The 6 labs that completed all 4 cycles
  • 3 Oral Fluids Pilot PT Cycles
  • The 9 labs that completed all 3 cycles

6
Cannabinoid Confirmation Methods
  • Urine - GC/MS
  • Hair- GC/MS (EI and NCI), GC/MS/MS
  • Oral Fluids- GC/MS (EI and NCI), GC/MS/MS

7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
Confirmation Methods for Cannabinoids
  • xxxx Did not test

11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
Confirmation Methods for Cannabinoids
  • xxxx Did not test

16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
Future Plans
  • Complete in-depth evaluation of confirmation
    testing for other analytes
  • Additional pilot PT cycles to clarify performance
    issues around cutoffs (e.g., precision and
    accuracy)
  • Complete in-depth evaluation of immunoassay tests
  • Additional pilot PT cycles to clarify performance
    issues around cutoffs (e.g., precision, and
    specificity)

20
Future Plans (cont.)
  • POCTesting
  • Evolve cutoffs and standards of testing
Write a Comment
User Comments (0)
About PowerShow.com